CSS
SGNT

Cubist Systematic Strategies’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Cubist Systematic Strategies’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,415
Closed -$29K – 2015
2016
Q1 		$29K Sell
2,415
-1,382
-36% -$19.4K ﹤0.01% 1515
2015
Q4 		$60K Sell
3,797
-2,618
-41% -$41.2K ﹤0.01% 1575
2015
Q3 		$98K Buy
6,415
+4,642
+262% +$100K 0.01% 1630
2015
Q2 		$43K Buy
+1,773
New +$42.5K ﹤0.01% 1721
2015
Q1 		– Sell
-12,852
Closed -$323K – 2231
2014
Q4 		$323K Buy
+12,852
New +$377K 0.02% 1161

Other funds holding SGNT

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Cubist Systematic Strategies's SGNT Position: Q2 2016 in Review

Cubist Systematic Strategies sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q2 2016, closing a stake of 2,415 shares — an estimated $29K sold.

Cubist Systematic Strategies first reported a position in SGNT in Q4 2014 and held it in 5 quarters. The position peaked at $323K in Q4 2014. 128 funds tracked by Wall St. Rank hold SGNT as of Q2 2016.

  • Cubist Systematic Strategies reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Cubist Systematic Strategies sold 2,415 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q2 2016, an estimated $29K.
  • Cubist Systematic Strategies first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 5 quarters.
  • Cubist Systematic Strategies's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $323K in Q4 2014.
  • 128 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q2 2016.

Based on Cubist Systematic Strategies's 13F filing for Q2 2016, filed 15 Aug 2016.